Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary Metastases
Clinical trial NCT04887298 · COMPLETED
Trial details
- NCT number
- NCT04887298
- Sponsor
- Moleculin Biotech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-05
- Primary completion
- 2022-09-29
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.